腹主动脉瘤修复术前压力测试未降低围术期心脏事件
高使用率中心与低使用率中心相比,主要不良心脏事件(MACE)风险反而更高(EVAR OR 1.78,OAR OR 1.99),1年死亡率无差异。结论认为常规术前压力测试的价值应重新评估,建议更有选择性地使用。
要点
- 各中心压力测试使用率差异大,但患者风险特征相似。
- 高使用率中心MACE风险更高,1年死亡率无差异。
- 常规术前压力测试的价值应重新评估,建议选择性使用。
核心结论
- 腹主动脉瘤修复术前压力测试未降低围术期主要不良心脏事件或1年死亡率。
- 高压力测试使用率中心调整后MACE风险反而更高。
- 常规术前压力测试的价值应重新考虑,建议更有选择性地使用。
研究设计与样本
- 基于血管质量倡议(VQI)的多中心回顾性队列研究。
- 比较压力测试最高五分位与最低五分位中心的结果。
主要发现
- EVAR术前压力测试使用率中位35.9%(5th百分位10.2%,95th百分位73.7%)。
- OAR术前压力测试使用率中位57.9%(5th百分位13.0%,95th百分位86.0%)。
- EVAR组有压力测试者平均VSG-CRI 5.6±2.1,无压力测试者5.4±2.1(P < .001)。
- OAR组有压力测试者平均VSG-CRI 5.1±2.0,无压力测试者4.8±2.1(P < .001)。
- EVAR后MACE率1.8%,OAR后11.6%;1年死亡率EVAR 4.6%,OAR 6.6%。
关键数值与推荐
- 高压力测试五分位中心EVAR后MACE调整OR 1.78(95%CI 1.37-2.30)。
- 高压力测试五分位中心OAR后MACE调整OR 1.99(95%CI 1.53-2.59)。
- 高压力测试五分位中心1年死亡率EVAR OR 1.18(95%CI 1.02-1.37),OAR OR 0.87(95%CI 0.65-1.17)。
- 高与低压力测试中心VSG-CRI无差异(EVAR 5.5±2.1 vs 5.5±2.1,P = .403;OAR 5.0±2.0 vs 4.9±2.0,P = .563)。
临床怎么用
- 不应常规对腹主动脉瘤修复术前患者进行压力测试。
- 应基于患者个体风险选择性使用压力测试。
- 需权衡广泛压力测试的相关成本与临床获益。
局限性
- 本研究为回顾性观察性研究,可能存在未测量混杂。
- 压力测试使用率基于中心层面,非个体随机分配。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Stress testing is often used before abdominal aortic aneurysm (AAA) repair. Whether stress testing leads to a reduction in cardiac events after AAA repair has remained unclear. Our objective was to study the national stress test usage rates and compare the perioperative outcomes between centers with high and low usage of stress testing. METHODS: We used the Vascular Quality Initiative to study patients who had undergone elective endovascular AAA repair (EVAR) or open AAA repair (OAR). We measured the usage rates of stress testing across centers and compared the Vascular Study Group of New England cardiac risk index (VSG-CRI) among patients who had and had not undergone preoperative stress testing. We determined the rate of major adverse cardiac events (MACE), a composite of perioperative myocardial infarction, stroke, heart failure exacerbation, and death across the centers. We compared the MACE and 1-year mortality between the centers in the highest quintile of stress test usage and the lowest quintile. RESULTS: We studied 43,396 EVAR patients and 8935 OAR patients across 324 centers. The median proportion of stress test usage across centers before EVAR was 35.9% and varied from 10.2% (5th percentile) to 73.7% (95th percentile), with similar variability for OAR (median, 57.9%; 5th percentile, 13.0%; 95th percentile, 86.0%). The mean VSG-CRI for the EVAR group with preoperative stress testing was 5.6 ± 2.1 compared with 5.4 ± 2.1 (P < .001) for the EVAR group without preoperative stress testing. The findings were similar for OAR, with a VSG-CRI of 5.1 ± 2.0 vs 4.8 ± 2.1 (P < .001) for those with and without preoperative stress testing, respectively. The rate of MACE was 1.8% after EVAR and 11.6% after OAR. The 1-year mortality was 4.6% for EVAR and 6.6% for OAR. The centers in the highest quintile of stress testing had a higher adjusted likelihood of MACE after both EVAR (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.37-2.30) and OAR (OR, 1.99; 95% CI, 1.53-2.59) but similar 1-year mortality (EVAR: OR, 1.18; 95% CI, 1.02-1.37; OAR: OR, 0.87; 95% CI, 0.65-1.17) compared with the centers in the lowest quintile. The VSG-CRI was not different between the high stress test centers (EVAR, 5.5 ± 2.1; OAR: 5.0 ± 2.0), and low stress test centers (EVAR, 5.5 ± 2.1; P = .403; OAR, 4.9 ± 2.0; P = .563). CONCLUSIONS: Stress test usage before AAA repair varied widely across Vascular Quality Initiative centers despite similar patient risk profiles. No reduction was observed in MACE or 1-year mortality among centers with high stress test usage. The value of routine stress testing before AAA repair should be reconsidered, and stress testing should be used more selectively, given these findings and the associated costs of widespread testing.
引用
- Columbo JA, Demsas F, Wanken ZJ, et al. Stress testing before abdominal aortic aneurysm repair does not lead to a reduction in perioperative cardiac events. J Vasc Surg. 2021. PMID: 33684471. doi:10.1016/j.jvs.2021.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。